机译:Bosutinib在真生治疗中慢性骨髓白血病患者患者65岁抗性/不耐受以前的酪氨酸 - 激酶抑制剂
Sapienza Univ Dept Translat &
Precis Med Policlin Umberto 1 Hematol Rome Italy;
Univ Bari Hematol Sect Dept Emergency &
Organ Transplantat DETO Bari Italy;
Tor Vergata Univ S Eugenio Hosp Hematol Rome Italy;
Azienda Unita Sanit Locale IRCCS Reggio Emilia Hematol Dept Reggio Emilia Italy;
Cardarelli Hosp Hematol Unit Naples Italy;
Univ Pavia Dept Mol Med &
Hematol Oncol Pavia Italy;
Univ Naples Federico II Dept Clin Med &
Surg Naples Italy;
Azienda Osped Univ Parma Hematol &
BMT Ctr Parma Italy;
Policlin S Martino IRCCS Hematol Clin Genoa Italy;
Univ Verona Dept Med Sect Hematol Verona Italy;
Univ Pisa Dept Clin &
Expt Med Hematol Pisa Italy;
Ca Foncello Hosp UOC Hematol Treviso Italy;
Padua Sch Med Dept Med Hematol &
Clin Immunol Padua Italy;
A Perrino Hosp UOC Hematol &
Marrow Transplantat Brindisi Italy;
Univ Turin Hematol Turin Italy;
Tor Vergata Univ S Eugenio Hosp Hematol Rome Italy;
Fdn Policlin Univ A Gemelli IRCCS Dipartimento Diagnost Immagini Radioterapia Oncol Rome Italy;
Univ Cagliari Ctr Trapianti Midollo Osseo Osped Businco Hematol Cagliari Italy;
Azienda Osped S Hematol Terni Italy;
Sapienza Univ Dept Translat &
Precis Med Policlin Umberto 1 Hematol Rome Italy;
Univ Verona Dept Med Sect Hematol Verona Italy;
Fdn IRCCS Ca Granda Osped Maggiore Policlin Hematol Div Milan Italy;
Univ Florence Hematol AOU Careggi Florence Italy;
Belcolle Hosp Hematol Viterbo Italy;
Tor Vergata Univ S Eugenio Hosp Hematol Rome Italy;
Univ Bari Hematol Sect Dept Emergency &
Organ Transplantat DETO Bari Italy;
Sapienza Univ Dept Translat &
Precis Med Policlin Umberto 1 Hematol Rome Italy;
bosutinib; chronic myeloid leukemia; elderly people; realamp; 8208; life clinical experience;
机译:在日本慢性骨髓白血病患者抗性/不耐受前期酪氨酸激酶抑制剂治疗中的长期治疗
机译:达沙替尼:从对伊马替尼耐药或不耐受的慢性粒细胞白血病患者的治疗到新诊断的慢性期慢性粒细胞白血病患者的治疗
机译:来自费城染色体阳性慢性骨髓白血病患者抗性或不耐受治疗的Bosutinib的开放标签安全性和疗效研究的长期患者报告的结果
机译:T315I突变BCR-ABL1酪氨酸激酶的新型抑制剂通过基于片段的药物设计治疗慢性粒细胞白血病
机译:慢性骨髓白血病患者诊断年龄的异质性的定量评估
机译:博舒替尼在费城染色体阳性慢性髓性白血病患者中对bosutinib的开放性安全性和有效性研究得出的长期患者长期疗效报告
机译:通过EQ-5D测定的Bosutinib治疗的依马替尼耐药或伊马替尼耐受的慢性粒细胞白血病患者的治疗方式与PSY55健康相关的生活质量
机译:针对癌症治疗的选定药物遗传学测试的系统评价:CYp2D6用于乳腺癌中的他莫昔芬,KRas用于结肠直肠癌中的抗EGFR抗体,以及BCR-aBL1用于慢性髓性白血病中的酪氨酸激酶抑制剂。技术评估报告